Signup Crypto ETF Stocks News

Wendy's ( WEN ) Q4 2024 Earnings Call Transcript

WEN earnings call for the period ending December 31, 2024.

Source: www.fool.com
February 13, 2025 | 17:45:12
Category: News

Rollins ( ROL ) Q4 2024 Earnings Call Transcript

ROL earnings call for the period ending December 31, 2024.

Source: www.fool.com
February 13, 2025 | 17:45:15
Category: News

Crocs ( CROX ) Q4 2024 Earnings Call Transcript

CROX earnings call for the period ending December 31, 2024.

Source: www.fool.com
February 13, 2025 | 17:45:18
Category: News

Lockheed Martin's Options: A Look at What the Big Money is Thinking - Lockheed Martin ( NYSE:LMT )

Whales with a lot of money to spend have taken a noticeably bullish stance on Lockheed Martin. Looking at options history for Lockheed Martin LMT we detected 9 trades. If we consider the specifics of each trade, it is accurate to state that 44% of the investors opened trades with bullish ...

Source: www.benzinga.com
February 13, 2025 | 17:45:25
Category: News

Starbucks's Options: A Look at What the Big Money is Thinking - Starbucks ( NASDAQ:SBUX )

Whales with a lot of money to spend have taken a noticeably bearish stance on Starbucks. Looking at options history for Starbucks SBUX we detected 27 trades. If we consider the specifics of each trade, it is accurate to state that 40% of the investors opened trades with bullish expectations and ...

Source: www.benzinga.com
February 13, 2025 | 17:45:30
Category: News

Decoding IonQ's Options Activity: What's the Big Picture? - IonQ ( NYSE:IONQ )

Investors with a lot of money to spend have taken a bullish stance on IonQ IONQ. We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga. Whether these are institutions or just wealthy individuals, we don't know.

Source: www.benzinga.com
February 13, 2025 | 17:45:35
Category: News

Agios Pharmaceuticals Reveals Encouraging Data From Rare Blood Disorder Study In Younger Patients Aged Below 18 Years - Agios Pharmaceuticals ( NASDAQ:AGIO )

Agios' ACTIVATE-Kids trial showed 31.6% of mitapivat-treated children met the hemoglobin response endpoint vs. 0% in the placebo group. Agios reported Q4 Pyrukynd revenue of $10.7M, exceeding the $9.33M consensus, with 130 patients on therapy and cash reserves of $1.5B.

Source: www.benzinga.com
February 13, 2025 | 17:45:59
Category: News

Neumora Therapeutics, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - NMRA - Neumora Therapeutics ( NASDAQ:NMRA )

NEW YORK, Feb. 13, 2025 ( GLOBE NEWSWIRE ) -- Levi & Korsinsky, LLP notifies investors in Neumora Therapeutics, Inc. ( "Neumora Therapeutics, Inc." or the "Company" ) NMRA of a class action securities lawsuit.

Source: www.benzinga.com
February 13, 2025 | 17:46:35
Category: News

Molson Coors Q4 Earnings & Sales Beat Estimates, Stock Up

TAP posts better-than-expected results in fourth-quarter 2024. Financial volumes fall 6.4% year over year, mainly led by lower shipments.

Source: www.zacks.com
February 13, 2025 | 17:47:00
Category: News

Need a Gaming Coach? There's an AI Agent for That

AI agents can now coach you through your video games, thanks to the Balance.fun companion platform and its soon-to-launch Ethereum token.

Source: decrypt.co
February 13, 2025 | 17:47:04
Category: News

© Natavest 2025 - 2026